Shanghai Medicilon Inc.

  Shanghai, China/San Diego,USA - August 2, 2023, ABM Therapeutics announced that its self-developed small molecule BRAF inhibitor ABM-1310 has obtained orphan drug qualification from the US FDA for the treatment of BRAF V600 mutant brain glioblastoma (GBM). In the research and development of ABM-1310, the  chemical FTE (Full-time equivalent)  team of Shanghai Medicilon Inc provided  drug discovery services  in a flexible cooperation mode.  It has laid a solid foundation for ABM Therapeutics' ABM-1310 to obtain the US FDA Orphan Drug Qualification. Medicilon Chemical FTE Team Facilitate Rapid Discovery of Innovative Drugs The chemical FTE team of Medicilon can serve clients in different stages of drug development, including the generation and optimization of hit compounds, the identification and optimization of lead compounds, synthesis amplification chemical process research and other services.  This collaboration model is based on client and project ...

  Recently, Ringene Biopharma, an innovative drug R&D company focusing on the development of drugs targeting RTK-RAS-MAPK signaling pathway, independently developed a new class of anti-tumor drugs, the irreversible pan-FGFR inhibitor RG002, which was approved clinical.  The indications are advanced malignant tumors. In the R&D of RG002, Shanghai Medicilon Inc. provides drug discovery sevices in the form of FTE collaboration to clinical application, including preclinical research,  drug discovery ,  pharmaceutical research  and  preclinical research  (pharmacy,  safety assessment ), which accelerated the research process of RG002. ❖      Medicilon’s FTE/FFS services In the early stages of new drug development, FTE (Full-time equivalent) is often used by drug discovery companies to synthesize the required structural fragments and/or potential candidate compounds to accelerate the drug screening process. Medicilon provides comp...

  Medicilon’s   chemical   department has comprehensive chemical research capabilities and facilities including medicinal chemistry, synthetic chemistry, process research and   analytical support , and professional synthetic technology. It has a good record of project advancement and the generation of preclinical drug candidates. We can quickly complete new drug development projects from compound screening to new drug clinical research declaration in a highly efficient and low-cost manner. Chemical FTE Service Our team is made up of a team of experienced chemists, who can provide customers with high-quality and efficient research services of various chemical molecular  synthesis . It can transform the small-scale synthesis method of the compound into a process route of several kilograms, which can ensure the completion of the project research within a very strict time limit. Chemical FTE services, synthesis of chemical intermediates and analogs, development and ...